Biomedical risk assessment is the process of giving smokers feedback on the physical effects of smoking using physiological measurements (for example: exhaled carbon monoxide measurement or lung function tests). It has been considered as a tool to encourage smokers to quit. This review includes 15 studies. Of them, only two found that biomedical risk assessment significantly increased long term quitting. In one study, smokers who had their lung function tested and the results explained in terms of lung age compared to their actual age were more likely to quit than people given the same test but without the explanation. In another study, light smokers who were shown images of their arteries were more likely to quit than those who were not shown images. Mixed quality evidence does not suggest that other types of biomedical risk assessment increase a smoker's chance of successfully quitting compared with standard treatments.
Does giving people feedback about the effects of smoking on their body help them to quit?
12 December 2012
This record should be cited as:
Bize R, Burnand B, Mueller Y, Rège-Walther M, Camain J-Y, Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD004705. DOI: 10.1002/14651858.CD004705.pub4
Assessed as up to date:
1 August 2012
More like this
- Are there ways to help partners to give more effective support to people who are trying to quit smoking
- Are stage-based interventions more effective than non-stage-based ones in helping smokers to quit?
- Can interventions delivered by mobile phones help people to stop smoking?
- Do competitions and incentives help smokers to quit in the medium to long term
- Does a combination of smoking cessation medication and behavioural support help smokers to stop?